Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.
์ข
๋ชฉ ์ฝ๋ AYTU
ํ์ฌ ์ด๋ฆAytu Biopharma Inc
์์ฅ์ผOct 20, 2017
CEODisbrow (Joshua R)
์ง์ ์82
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃOct 20
์ฃผ์7900 E. Union Avenue
๋์DENVER
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ80237
์ ํ17204376580
์น์ฌ์ดํธhttps://aytubio.com/
์ข
๋ชฉ ์ฝ๋ AYTU
์์ฅ์ผOct 20, 2017
CEODisbrow (Joshua R)
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์